In conclusion, understanding the mechanism behind the reversible silencing of the TERT gene during differentiation, embryonic development, and aging, or conversely, its activation in cancer, has potential for informing future clinical applications, cancer treatment, diagnosis, prognosis, and cellular aging research. The gene discussed is TERT; the disease is cancer.